The Efficacy and Mechanism Evaluation Programme is accepting stage 1 applications to their researcher-led workstream.
The EME Programme funds ambitious studies evaluating interventions that have the potential to make a step-change in the promotion of health, treatment of disease and improvement of rehabilitation or long-term care. Within these studies EME supports research to improve the understanding of the mechanisms of both diseases and treatments.
The programme supports translational research evaluating a wide range of novel or re-purposed interventions. The interventions may include diagnostic or prognostic tests and decision-making tools, drugs or biological compounds, psychological treatments, medical devices, and public health initiatives delivered within the NHS.
The EME Programme primarily supports clinical trials, and other robustly designed studies that test the efficacy of interventions. The interventions should have the potential to improve patient care or benefit the public. The programme will only support studies where there is sufficient evidence that the intervention might work in man, i.e. that there is ‘proof of concept’.
Innovative study designs involving stratification, the use of routinely collected digital data or novel methodologies are strongly encouraged.
In order to apply you will need to carefully review the:
All primary research projects are expected to establish a programme appointed Study Steering Committee and it is important that you read the TSC/SSC Guidance before completing your application. Costs incurred by this committee should be included in the budget as appropriate.
The NIHR is holding a webinar on 25 January 2021, 13:00, to support applications to this funding opportunity. Complete the registration form on the NIHR Website.
Visit funding web page